• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 68Germ cell tumor study selection criteria

Study DesignPopulationInterventionComparatorsOutcomesTimeSetting
Controlled trial, cohort, case-seriesPediatric patients (0-21-yr) with relapsed diseaseTandem (Auto Auto) HSCTSingle (Auto) HSCTOS; EFS (DFS; PFS); long-term adverse events; QOLAll durations of followupIn-patient

Auto = autologous; DFS = disease-free survival; EFS = event-free survival; HSCT = hematopoietic stem-cell transplant; OS = overall survival; PFS = progression-free survival; QOL = quality of life

From: Systematic Reviews

Cover of Hematopoietic Stem-Cell Transplantation in the Pediatric Population
Hematopoietic Stem-Cell Transplantation in the Pediatric Population [Internet].
Comparative Effectiveness Reviews, No. 48.
Ratko TA, Belinson SE, Brown HM, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.